MZ
Therapeutic Areas
Compugen Pipeline
| Drug | Indication | Phase |
|---|---|---|
| COM701 (anti-PVRIG) | Advanced solid tumors | Phase 1/2 |
| COM902 (anti-TIGIT) | Advanced solid tumors | Phase 1 |
| Bispecific Antibody Programs | Undisclosed cancers | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| COM701 (anti-PVRIG) | Advanced solid tumors | Phase 1/2 |
| COM902 (anti-TIGIT) | Advanced solid tumors | Phase 1 |
| Bispecific Antibody Programs | Undisclosed cancers | Preclinical |